Shen, C., Lu, C., Cheng, C., Li, K., Kuo, Y., Wu, C., . . . Yu, C. (2024). Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases. Biomedicines, 12(8), 1699. https://doi.org/10.3390/biomedicines12081699
Chicago Style (17th ed.) CitationShen, Chieh-Yu, et al. "Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases." Biomedicines 12, no. 8 (2024): 1699. https://doi.org/10.3390/biomedicines12081699.
MLA (9th ed.) CitationShen, Chieh-Yu, et al. "Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases." Biomedicines, vol. 12, no. 8, 2024, p. 1699, https://doi.org/10.3390/biomedicines12081699.